Company intelligence / Profile preview
Bioinova
- Ownership
- Private
- Employees
- ~12
- Development stage
- Other
Overview
Bioinova develops innovative stem cell-based therapies and advanced therapy medicinal products. The company has launched diagnostic products such as the BiCoV™ set for RNA isolation in PCR testing. Its pipeline includes solutions for regenerative medicine across multiple therapeutic areas. Clinical results are not detailed publicly but the company is active in translational research with ongoing product development[1][2].
- Therapeutic areas
- RheumatologyOphthalmologyImmunologyDermatologyNeurology
- Modalities
- Stem cell-based therapiesAdvanced Therapy Medicinal Products (ATMPs)Biomaterials for regenerative medicine[1][2][4]
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Bioinova.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioinova.